Inovio Pharmaceuticals Inc (INO)

[Lakers_w]

? 1Q22: COVID-19 AZD7442-cloned dMAb® P1 Start
11/15/20: As part of DARPA's two-year
$37M
grant, INOVIO and Wistar teams will construct COVID-19 dMAb candidates mirroring AstraZeneca's traditional recombinant monoclonal antibody candidates currently being tested in clinical trials to treat COVID-19. dMAb candidates can be quickly developed and produced in vivo, offering a cost-effective and scalable therapeutic and preventive option for treatment of SARS-CoV-2 virus infection. The dMAbf candidates will then be advanced into preclinical studies and then into rigorous, first-in-human clinical trials within one year of funding.

The antibody treatment, known as AZD7442, has shown to be highly effective at preventing Covid-19 in people who may not respond well to vaccines. AZN applied for EUA in Oct 2021, and has agreed to supply US government 700K doses.
https://medicaldialogues.in/news/industry/pharma/astrazenecas-antibody-shot-83-effective-at-preventing-covid-84757?infinitescroll=1